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Disclosure of medication error in a pediatric 
intensive care unit
Revelação da ocorrência de erro de medicação em unidade de 
cuidados intensivos pediátricos
ORIGINAL ARTICLE
INTRODUCTION
A medication error is an avoidable event occurring at any phase of the 
medication use process, which may or not harm the patient.  Medication 
error damage characterizes an avoidable adverse drug event, defined as 
harm or injury, either temporary or permanent, occurring from inappro-
priate use, including lack, of the medication.(1,2) 
In the context of the patient safety, it is consensual that errors in health 
care practice regularly occur, and result from a collection of factors that 
are inherent to the human nature and system complexity.(3) 
Although many errors cause no major consequences, others may result 
in serious harm to the patient and family, ranging from disabilities to 
death.(4) 
Considering all possible types of health care errors, several studies evi-
dence that medication errors are the most common, and also the most 
frequent cause of adverse events.(1,5) 
Medication errors have been focused by professionals, institutions and 
health authorities due to their contribution to increased morbidity, hos-
pital stay and health system costs, involve legal issues and compromise the 
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ABSTRACT 
Objective: To describe the fre-
quency medication error dis closure 
to the team and to the family in an 
oncology pediatric patients’ intensive 
care unit. 
Methods: This was a descriptive 
and exploratory study performed be-
tween March 1 and May 31, 2008. A 
medi cation error report form was de-
veloped and implemented, to be com-
pleted by the professionals involved 
in the unit’s medication process. 
Results: The sample consisted of 
71 forms collected over the 92 col-
lection days. After medication error 
detection, the event was not reported 
to the pediatric intensive care unit’s 
team in 34 (47.9%) cases. In the 37 
reported to the team cases, for most 
of them (48.7%) the physician was 
the professional communica ted. The 
event was not disclosed to the pa-
tient/family in 95.8% of medication 
error reports. 
Conclusions: Although the litera-
ture recommends disclo sing the er-
rors, this is not done in the studied 
pediatric intensive care unit. 
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quality of patient’s assistance.(6,7) This issue has been 
increasingly approached in several countries, includ-
ing Brazil, aiming to assure the patientsafety.(8) 
It is estimated that among all hospitalized patients 
about 3% will develop a serious adverse drug event 
during the hospitalization. Although the frequency is 
similar for both adults and children, the risk for po-
tentially harmful errors is three times higher in pedi-
atric patients.(9-10) 
Literature data estimate the incidence of medica-
tion errors in pediatric intensive care units (PICU) 
as ranging between 22 and 59 errors/1000 doses, and 
2.5% of children admitted to these units experience 
adverse drug events.(10) 
Analyzing 68 medical charts of patients of three 
pediatric units of an university hospital in the city 
of São Paulo, including one PICU, the investigators 
found 1,717 recorded errors, corresponding to 21.1% 
of the total 8,152 prescribed drugs doses or solutions. 
The omission errors, defined as dose omission or lack 
of record of execution, was the most frequent type, 
corresponding to 75.7%.(11) 
Historically, due to the trend to blame individu-
als health care professionals are instinctively reluc-
tant and defensive regarding an error disclosure and 
discussion.(12)  Although disclosing an error is a both 
moral and ethic obligation, little discussion is held on 
this issue due to uncertainty about the patient’s reac-
tion and the fear of disciplinary and legal actions.(13) 
Unfortunately this long lasting culture of silence 
about errors resulted in lost opportunities both to 
learn from the events and promote the patient safety. 
Additionally, as health care professionals this behavior 
may be considered disloyal for the patients, families 
and the community, by not telling the truth and wast-
ing a regrettable but valuable opportunity to improve 
the quality of health care.(12) 
Currently, an open error discussion has been con-
sidered a foundation for the patient’s safety move-
ment. Professionals are being stimulated to commu-
nicate and discuss errors with their colleagues and in-
stitution, aiming that each event is analyzed and new 
errors prevented.(14) 
With the objective to start and stimulate this dis-
cussion one of the most used data collection methods 
is the errors and adverse events reporting process. It 
involves a detailed report of the circumstances sur-
rounding the error by the professionals directly in-
volved to the process, being in this research the medi-
cation practice. 
It is recommended that whenever a professional 
detects an error, a report form is completed, being 
subsequently classified and analyzed.(15) The reports 
act as information sources, allowing the identification 
of causes, types and relevant predisposing factors, in-
dicating situations required to be changed both in the 
structure and process.(16)  
From the above presented purposes, this study 
aimed to describe medication error disclosure to the 
health care team and family in a pediatric oncology 
intensive care unit.
METHODS
Descriptive and exploratory study conducted in a 
PICU of a reference hospital for children and adoles-
cents cancer patients in the city of São Paulo. The data 
were collected from March 1 to May 31, 2008, after 
the trial was approved by the institution’s Ethics Com-
mittee under the number 1252/06. 
This PICU has six beds for multidisciplinary inten-
sive care of oncologic therapy patients with different 
severity levels, undergoing either clinical or surgical 
interventions. In addition to oncologic emergencies, 
are admitted to the PICU patients submitted to neu-
rological, thoracic, gastrointestinal, genitourinary and 
orthopedic surgery. The yearly mortality rate is 10%. 
The patientsproceed from Chemotherapy Outpatient 
Clinic, Regular Ward, Intermediate Care Unit, Bone 
Marrow Transplantation Unit and Operating Room. 
The sample was composed by the medication er-
ror notification forms completed by the professionals 
involved in the unit’s medication process during the 
collection period, after written informed consent was 
obtained. When a duplicated error notification was 
identified, only one notification for each event was 
considered.
The data collection tool, titled Medication Error 
Notification Form was developed by the authors to 
be used in this study, aiming to encompass all recom-
mendations to allow an error notification process. To 
embrace the study variables and the literature recom-
mendations the tool included aspects related to the 
patient, the moment of medication error occurence, 
the medication, the errors’ consequences, the proce-
dures after the error identification and the profession-
als involved in the notification. A box was provided 
for free text description of the event, aiming a more 
reliable error description.
After the elaboration, the notification form was 
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evaluated by three acknowledged professionals, as 
evidenced by their bibliographic productivity in this 
area, being one nurse, one physician and one pharma-
cist. Once implemented the received suggestions, the 
final tool was implemented in the PICU for this study 
conduction.
To implement the data collection tool, a training 
session was held with the unit medication system pro-
fessionals with the objective to promote understand-
ing on questions related to patient safety, medication 
errors and form completion.  The training session was 
conducted by one of the authors who was also a PI-
CU’s nurse. The health care team consisted of unit’s 
intensive care physicians, residents, nurses, techni-
cians and nurse assistants, and institution’s pharma-
cists, reaching a participation that included 80% of 
the physicians, 83% of the nursing team, and 100% 
of the pharmacists. The reason why less than 100% 
of the medical and nursing teams participated in the 
training was because some were unavailable during the 
training days (although previously scheduled) and due 
to medical leaves during the study. The professionals 
were instructed to complete a notification whenever a 
medication error was identified. 
It should be remarked that the notification was 
both anonymous and voluntary. This is considered 
fundamental to the notification process success, in-
creasing the number of reports, evidencing details on 
the event and contributing for the development of a 
confidence environment. 
After completed the forms were inserted into a 
sealed box and weekly collected by one of the investi-
gators. The data were stored in electronic sheets, and 
descriptively presented in figures and tables. 
The reported medication errors classification was 
conducted by type of error according to the National 
Coordinating Council for Medication Error Report-
ing and Prevention – NCC MERP, and the American 
Society of Hospital Pharmacists – ASHP criteria, as 
shown on Chart 1.(17-18) 
The results were descriptively presented, and no 
statistical analysis was conducted.
RESULTS
During the study period, 71 forms were received 
and 110 medication errors were reported. 
The retrieved information showed that after the 
medication error identification, the event was not 
communicated to the team in 34 (47.9%) of the times. 
In the 37 circumstances when the events were com-
municated, most of the communications were to phy-
sicians (48.7%), followed by communication to the 
nurses (43.2%). In two (5.4%) situations communi-
cation was reported, however not mentioning the pro-
fessional category. 
Of the 51 medication errors communicated to 
the team, the most frequently reported error was the 
omission error (29.4%). Among the errors not report-
ed to the team the dose (22.0%) and administration 
(20.3%) errors were the most common, respectively 
(Table 1).
In 95.8% of the reports the medication errors were 
not disclosed to the patient and family. In the two 
cases (2.8%) reported as communicated to the family, 
the disclosure was made by the intensive care physi-
cian or the nurse. In one report (1.4%) the reporter 
was not able to tell if the error was disclosed to the 
patient and family.
DISCUSSION
The notification system as a tool for errors and 
adverse events detection has been shown to be very 
importantonce it allows a detailed report of the event’s 
circumstances by the directly involved professionals. 
We believe that the identification of adverse events 
during the patients’ care is extremely relevant, aiming 
to improve patients’ quality of care and safetyand to 
enable the implementation of good professional prac-
tices. 
During the study period several medication errors 
were computed. The variations in the units’ charac-
teristics and the diffent definitions and methodolo-
gies used in the studies on this subject render difficult 
comparing the results. 
As this subject was not previously approached in 
the studied PICU, we couldn’t compare the num-
ber of reported versus occurring errors. This is one 
limitation for this study. Specialists suggest that this 
analysis should be done by the simultaneous events 
record through direct observation methods, which 
could evidence the error notification reach and char-
acteristics.(19) 
Another limitation was the medication errors un-
derreporting, the most important drawback of this 
data collection method. This can be changed through 
the development of a culture of safety toward a non-
punitive environment and focused on analysis of the 
medication system failures, characterized by sharing 
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Table 1 – Type of medication errors reported in a pediatric intensive care unit, according to the error communication to the 
team
Types of medication error Error communicated to the team
Yes No
N (%) N (%)
Prescription error 10 (19.6) 8 (13.5)
Dispensing error 2 (3.9) 1 (1.7)
Omission error 15 (29.4) 10 (17.0)
Wrong time error 2 (3.9) 7 (11.9)
Unauthorized drug error 1 (2.0) 1 (1.7)
Dose error 5 (9.8) 13 (22.0)
Wrong drug preparation error 6 (11.8) 3 (5.1)
Administration error 8 (15.6) 12 (20.3)
Deteriorated drug error 1 (2.0) 3 (5.1)
Monitoring error 1 (2.0) 1 (1.7)
Total 51 (100.0) 59 (100.0)
Chart 1 – Classification of the reported medication errors, according to the type of error.
Type of error Definition
Prescription error Wrong drug choice (based on indication, contra-indication, known allergies, availability of 
another more effective therapy); incorrect dose prescription; incorrect form of administra-
tion, infusion rate, or pharmaceutical form; illegible prescription; incomplete prescription.
Dispensing error Incorrect distribution of the patient’s prescribed medicinal product.
Omission error The prescribed medicinal product was not dosed to the patient, or the administration was 
not recorded.
Wrong time error Medicinal product given out of the time prescribed by the physician or nurse who sche-
duled the prescription. Is defined as error: administration in advance or delayed above 30 
minutes for immediate action drugs (e.g., vasoactive drugs, analgesics); or administration 
in advance or delayed above one hour for long action drugs (e.g. antibiotics, antacids). 
Unauthorized drug error Giving a non-prescribed medicinal product; wrong product administration to the patient; 
administration of the product to the wrong patient; administration of a product not au-
thorized by the physician; use of outdated prescription. 
Dose error Administration of a medicinal product in a dose above or below the prescribed dose; admi-
nistration of an extra dose; administration of a double dose. 
Wrong dosage-form error Administration of a medicinal product in a pharmaceutical form that is different from the 
prescribed.
Wrong drug preparation error Incorrectly formulated or manipulated medicinal product (incorrect reconstitution or di-
lution, association with physically or chemically incompatible drugs); inappropriate stora-
ge; aseptic technique failure; incorrect drug identification; inappropriate choice of infusion 
devices.
Administration error Aseptic technique failure; technical administration fault; administration in a different way 
than the prescribed; product administration in a wrong site; incorrect infusion rate admi-
nistration; association with physically or chemically incompatible drugs; devices failure or 
problems with infusion therapy devices; or incorrect administration of prescribed products.
Deteriorated drug error Administration of an expired product, or with impaired physical or chemical integrity.
Monitoring error Failure to monitor the clinical and laboratory data before, during and after a product ad-
ministration to evaluate the patient’s response to the prescribed therapy.
Compliance error Inappropriate patient or caregiver behavior regarding the participation in the proposed 
therapy.
Other medication errors Any other errors not described above.
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stating the error and an explanation of what happened 
and why the error occurred, and want to know the 
implications to their health, the actions to prevent its 
recurrence, in addition to apologies.(13,20) 
Evaluating the parental preferences regarding dis-
closure, notification and legal actions in case of errors 
during their children care, a study evidenced that 99% 
of the respondents said that they would prefer the er-
ror disclosure, independently of its severity. These re-
sults suggest that the error disclosure could reduce the 
possibilities of legal actions against the professionals 
when compared to learning about the error by other 
means.(13) 
From the healthcare professionals perspective, al-
though the literature evidences that they agree with 
the relevance of disclosing an error,(21) three aspects 
are identified as obstacles: the difficulty of admitting 
the error, the fear of involving other professionals, and 
the possibility of suffering ethical or legal actions.(22) 
Studies focused on the decision to disclosure or not 
an error to the patient and family evidence rates con-
sidered low of event disclosure, uncertainty on when 
and how to disclosure an error, trend to conceal the 
fault when there aren’t consequences or those are not 
significant, in addition to divergences regarding the 
responsible professional for disclosing the error, being 
mentioned physicians, nurses or institution’s respon-
sible professionals.(23,24) 
Errors, mainly when not resulting in harm or caus-
ing minimal injuries, are generally not perceived by 
the patient and family. specialists suggest that when 
considering an error disclosure, the healthcare pro-
fessionals should balance their potential personal 
and professional conflicts with the patient’s interest. 
Should also consider his/her personal integrity protec-
tion, the professional obligation to prevent the error 
recurrence, the risk of impairment his/her relation-
ship with the patient and family and the patient’s 
right to know the truth. Additionally, there are situa-
tions where the potential error disclosure harms may 
exceed its benefits. Considering that the healthcare 
professional is responsible for promoting the patient’s 
welfare and preventing harms and injuries, it becomes 
highly relevant a careful evaluation of what, when and 
how disclose, in addition to who should do it.(25) 
Although the current literature recommends dis-
closing the errors, there are few evidences to guide 
the professionals on how to appropriately do it, i.e., 
to obtain the best outcomes. Therefore, more studies 
are warranted involving the decision to disclosure, the 
results with all involved professionals and the institu-
tion’s leaders involvement in the promotion of patient 
safety.(16) 
The lack of communication to the team in 47.9% 
of the events corroborates the literature, evidencing 
a historical trend to conceal health care faults.(12) Al-
though the studies emphasize the error as a conse-
quence of a set of systemic failures, the culture of 
professional autonomy and individual responsibility 
still prevails. Thus, the fear of jeopardizing his/her 
reputation and of ethical and legal actions, prevent 
the events communication and their consequent 
analysis.(14) 
We could not find any other Brazilian studies ad-
dressing the events communication to the team. It 
should be emphasized that overlooking an error leads 
to the implementation of interventions both aimed 
for prevention and treatment of patient’s consequenc-
es and for its future recurrence prevention.  
Communication to another professional was re-
ported in 52.1% of the notifications, being physicians 
and nurses, respectively, the professionals informed in 
most of the times. This result can be ascribed both 
to their function within the medication process and 
their relevance in the studied unit. However, it should 
be highlighted the ethical fault involved in failing to 
communicate the medication error to the physician 
due to the events inherent risks and the medical attri-
butions regarding drug therapy and the identification 
of measures to correct or reduce the error’s harmful 
effects.
The most frequently notified type of medication 
error was the omission error. Dose and administration 
errors, respectively, were the most frequently not com-
municated to the team. The impossibility to confirm 
the drug administration can be the main reason for 
communication of omission to the team. The decision 
to dose or not the not checked drugs should be taken 
from analysis of the error circumstances. 
The medication error was not disclosed to the pa-
tient and family in 95.8% of the cases, evidencing that 
this kind of communication is not a common practice 
in this studied unit. 
The review of medication errors notification from 
a pediatric hospital in the United Kingdom evidenced 
that in 48% of the cases the parents were not in-
formed, and this result was considered unexpectedly 
high by the investigators.(20)
Recent researches on the subject show that in such 
situations the patients expect explicit declarations 
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disclosure process, and the possible consequences of 
either disclosing or not.(21)
CONCLUSION
The results evidenced that medication error disclo-
sure is not a common practice in the studied PICU. 
RESUMO
Objetivo: Descrever a ocorrência de comunicação do 
erro de medicação à equipe e família em uma unidade de 
cuidados intensivos pediátricos para atendimento de paci-
entes oncológicos. 
Métodos: Estudo descritivo e exploratório, realizado no 
período de 1º de março a 31 de maio de 2008. Foi elaborada e 
implantada na unidade de cuidados intensivos pediátricos uma 
ficha de notificação de erros de medicação. A ficha deveria ser 
preenchida pelos profissionais envolvidos no sistema de medica-
ção da unidade no período definido para coleta de dados.
Resultados: A amostra foi composta por 71 fichas co-
letadas no período de estudo. Após a detecção do erro de 
medicação, a ocorrência não foi comunicada à equipe em 
34 (47,9%) situações. Nos 37 casos nos quais os eventos 
foram comunicados, o médico (48,7%) foi aquele que mais 
recebeu a informação. Em 95,8% dos relatos a ocorrência 
não foi informada ao paciente e família. 
Conclusão: Embora a literatura atual preconize a revela-
ção do erro, tal prática não constitui atividade freqüente na 
unidade de cuidados intensivos pediátricos estudada. 
Descritores: Erros de medicação; Segurança do paci-
ente; Unidades de terapia intensiva pediátrica; Enfermagem 
pediátrica
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